Order Article Reprints

Liu Y, Zhou Y-Q, Nie L, Zhu S-S, Li N, Wu Z-H, Wang Q, Qi J, Wu B-Y, Chen S-Q, et al. BR109, a Novel Fully Humanized T-Cell-Engaging Bispecific Antibody with GPRC5D Binding, Has Potent Antitumor Activities in Multiple Myeloma. Cancers. 2023; 15(24):5774. https://doi.org/10.3390/cancers15245774

Liu, Ying, Ya-Qiong Zhou, Lei Nie, Shan-Shan Zhu, Na Li, Zhen-Hua Wu, Qi Wang, Jian Qi, Bing-Yuan Wu, Shu-Qing Chen, and et al. 2023. "BR109, a Novel Fully Humanized T-Cell-Engaging Bispecific Antibody with GPRC5D Binding, Has Potent Antitumor Activities in Multiple Myeloma" Cancers 15, no. 24: 5774. https://doi.org/10.3390/cancers15245774

Liu, Y., Zhou, Y.-Q., Nie, L., Zhu, S.-S., Li, N., Wu, Z.-H., Wang, Q., Qi, J., Wu, B.-Y., Chen, S.-Q., & Wang, H.-B. (2023). BR109, a Novel Fully Humanized T-Cell-Engaging Bispecific Antibody with GPRC5D Binding, Has Potent Antitumor Activities in Multiple Myeloma. Cancers, 15(24), 5774. https://doi.org/10.3390/cancers15245774